Opioids elicit antinociception in mammals through three distinct types of receptors designated as m, k and d. However, it is not clear what type of opioid receptor mediates antinociception in non-mammalian vertebrates. Radioligand binding techniques were employed to characterize the site(s) of opioid action in the amphibian, Rana pipiens. Naloxone is a general opioid antagonist that has not been 
Introduction
effects of a number of opioid agonists in amphibians have been well characterized using the acetic acid test [22] . The It is known that opioids produce antinociception in antinociception produced by opioid agonists in amphibians mammals and analgesia in humans through the activation was shown to be opioid receptor mediated as it was of one or more distinct types of opioid receptors. Evidence significantly blocked by the general opioid antagonists, for the multiplicity of opioid receptors in mammals naloxone and naltrexone [32, 35] . Selective m, k, and d mediating antinociception originated with behavioral opioid agonists elicit consistent and potent antinociception studies [16] , was validated by radioligand binding studies following systemic or central administration in Rana [8, 14] and was further confirmed with the identification of pipiens [31, 32, 36] . Interestingly, the relative antinocicepgenes for three distinct types of opioid receptors [26] .
tive potency of selective m, k and d opioid ligands in Whereas the multiplicity of opioid receptors in mamamphibians and rodents is highly correlated in both mals is certain, it has not been shown that the opioid systemic and intraspinal administration studies [31, 32] . actions in non-mammalian vertebrates are mediated by Based on these findings, differences in the opioid receptor more than one type of opioid receptor. The antinociceptive proteins between mammals and amphibians would not be expected. Recently, data from behavioral studies in amphibians highly-selective opioid antagonists administered intraspi-nally produced a surprising finding: highly-selective an-11,11-dimethyl-2,6-methano-3-benzazocin-8-ol hydrochlotagonists for m, k, and d opioid receptors were not ride (bremazocine), 17,179-bis(Cyclopropylmethyl)-selective in amphibians [34] . That is, the m-selective 6, 69, 7, 79-tetrahydro-4, 5, 49, 59-diepoxy-6, 69-(imino) [7, As with the association points (10 measurements) where specific binding was data, the one phase equation was the best fit. For saturation measured. Nonspecific binding was defined by a parallel analysis the data were first fit to the rectangular hyperbolic series of tubes containing 10 mM naltrexone. The dissociafunction followed by linear transformation (Scatchard, tion component was accomplished by allowing the bound / free versus bound). Analysis of the rectangular radioligand and homogenate to bind to equilibrium at hyperbola was used to obtain apparent affinity (K ) and D which point further binding was blocked by the addition of density (B ) data. In competition experiments, the conmax 10 mM naltrexone at various time points (10 measurecentrations of unlabeled ligand that bound to half of the ments) where specific binding was measured.
binding sites at equilibrium (K ) were calculated by i GraphPad using the correction of Cheng and Prusoff [6] 2.5. Saturation studies which corrects for the concentration of radioligand as well as the affinity of the radioligand for its binding site. Saturation analysis was performed by measuring specific Competition curves were fitted to one-or two-site binding binding over increasing concentrations (0.5-70 nM) of models, to determine to which the data were best fit, using [ H]-naloxone (10 nM) with increasing concentrations (15) of unlabeled ligand (0.01 nM-100 mM). 10 mM Kinetic analysis was performed to determine the time naltrexone was used to define nonspecific binding. Binding needed to attain the condition of steady-state as well as the reactions proceeded as described in the binding assay.
rate constants for association and dissociation. Kinetic Fig. 1 .
cord tissue is shown in Fig. 2 . Scatchard analysis of these Association studies (Fig. 1A) analysis of the comparison between one and two site models yielded a best fit for the one site model (see Table  3 .
Competition analysis 1 for results of F-test and significance).
In order to clarify drug interaction with particular 3.2. Saturation studies receptor types, inhibition experiments were performed with 
Discussion

Opioid action in amphibians
The study of opioid receptor expression in phylogenetically different species has played a significant role in the understanding of opioid receptor pharmacology [5, 20] . It is widely recognized that three distinct receptors mediate the effects of opioids in mammals. However, previous behavioral and binding studies in Rana pipiens suggest the possibility of a single opioid receptor which may mediate the actions of m, k and d opioids [19, 34] . The present results are the first to document the binding characteristics 3 of [ H]-naloxone in Rana pipiens spinal cord homogenates. Furthermore, the present data are the first to use highly-selective opioid antagonists in a competitive binding assay using central nervous system tissue from a non-mammalian vertebrate species.
Naloxone binding affinity and density
Numerous mammalian binding studies have shown that opioid agonists elicit antinociception through m, k and d opioid receptors in both brain and spinal cord tissue homogenates [3, 9, 11, 15, 21, 24, 33, 41] . Kinetic analysis of Table 2 . Fig. 4 shows the correlation between brain and fmol / mg protein [11, 28, 37] . [23, 28, 37] . The K values for [ H]-naloxone binding in be highly correlated (see Fig. 4 ). Additionally, in bei frog spinal cord ranged from 2.58 nM for bremazocine to havioral studies in this lab, systematically administered 84 mM for deltorphin. As is shown in Table 2 , d receptor bremazocine showed partial agonist / antagonist properties ligands and most k receptor agents were weak competitors as it significantly blocked the antinociception produced by 3 3 of [ H]-naloxone binding. The strong competition of [ H]-naloxone binding by bremazocine is interesting as it is classified as a k-selective agonist in mammalian studies [10] , but has been considered a non-selective antagonist in previous binding studies [4, 40] . Additionally, in behavioral which was repeated three times. Fig. 4 . This were cloned [13] . consistency in K values between brain and spinal cord has
In conclusion, Rana pipiens represents a unique noni also been observed in the rat [15] . mammalian model for which there is a well-established behavioral assay for testing antinociception elicited by 4.4. Competition binding with highly-selective opioid opioid ligands. Further studies employing radiolabeled antagonists selective agonists are needed to fully characterize the sites of opioid binding in the amphibian and are near compleThe finding that naloxone bound to a single high-affinity tion. Finally, the ultimate determination of the number and site in amphibian spinal cord and that m, k and d opioids type of distinct opioid receptors in amphibians will come could complete with naloxone may be suggestive of a from receptor cloning studies that are currently in progress single-type of opioid receptor binding site. To further test in our lab and elsewhere. this hypothesis, the selective opioid antagonists were employed. In mammals these highly selective m, k and d antagonists affect the binding of opioid agonists only at Acknowledgements their respective receptors [38, 39] . As mentioned above, behavioral studies revealed a lack of selectivity of these 37 (1988) and a much lesser affinity for the other two opioid 555-556. receptors [26] . The similar affinities of the selective 
